India's Cadila Seeks To Cut The Pain Of GLP-1 Injectables As It Goes For Safety Studies Of Novel Oral Compound
This article was originally published in The Pink Sheet Daily
Executive Summary
Researchers at the sprawling Zydus Research Center located near the Western Indian city of Ahmedabad are upbeat about their latest finding - a novel orally administered GLP-1 agonist named ZYOG1- now ready to be tested on humans.